Abstract:As a bioactive triterpenoid, squalene is widely used in the food industry, cosmetics, and pharmacology. Squalene's major commercial sources are the liver oil of deep-sea sharks and plant oils. In this study, we focused on the enhancement of squalene biosynthesis in Yarrowia lipolytica, with particular attention to the engineering of acetyl-CoA metabolism based on genome-scale metabolic reaction network analysis. Although the overexpression of the rate-limiting endogenous ylHMG1 (3-hydroxy-3-methylglutaryl-CoA reductase gene) could improve squalene synthesis by 3.2-fold over that by the control strain, the availability of the key intracellular precursor, acetyl-CoA, was found to play a more significant role in elevating squalene production. Analysis of metabolic networks with the newly constructed genome-scale metabolic model of Y. lipolytica iYL_2.0 showed that the acetyl-CoA pool size could be increased by redirecting carbon flux of pyruvate dehydrogenation towards the ligation of acetate and CoA or the cleavage of citrate to form oxaloacetate and acetyl-CoA. The overexpression of either acetyl-CoA synthetase gene from Salmonella enterica (acs*) or the endogenous ATP citrate lyase gene (ylACL1) resulted in a more than 50% increase in the cytosolic acetyl-CoA level. Moreover, iterative chromosomal integration of the ylHMG1, asc*, and ylACL1 genes resulted in a significant improvement in squalene production (16.4-fold increase in squalene content over that in the control strain). We also found that supplementation with 10 mM citrate in a flask culture further enhanced squalene production to 10 mg/g DCW. The information obtained in this study demonstrates that rationally engineering acetyl-CoA metabolism to ensure the supply of this key metabolic precursor is an efficient strategy for the enhancement of squalene biosynthesis.

Enhanced squalene biosynthesis in Yarrowia lipolytica based on metabolically engineered acetyl-CoA metabolism.

Efficient synthesis of squalene by cytoplasmic-peroxisomal engineering and regulating lipid metabolism in Yarrowia lipolytica

Metabolic engineering of Yarrowia lipolytica for high-level production of squalene

Remodeling the Homologous Recombination Mechanism of Yarrowia Lipolytica for High-Level Biosynthesis of Squalene

Biosynthesis of Squalene by Introducing Hybrid MVA Pathway in Escherichia coli

Metabolic engineering of Yarrowia lipolytica for improving squalene production

Genetic and bioprocess engineering to improve squalene production in Yarrowia lipolytica

Sustainable biosynthesis of squalene from waste cooking oil by the yeast Yarrowia lipolytica

Engineering peroxisomal biosynthetic pathways for maximization of triterpene production in Yarrowia lipolytica

Improved Squalene Production Through Increasing Lipid Contents in Saccharomyces Cerevisiae

Increased Accumulation of Squalene in Engineered Yarrowia lipolytica through Deletion of PEX10 and URE2

Metal Cofactor Regulation Combined with Rational Genetic Engineering of Schizochytrium Sp. for High‐yield Production of Squalene

Metabolism Balance Regulation for Squalene Production by Disturbing Triglyceride (TAG) Synthesis in Schizochytrium Sp.

Metabolic Engineering of Saccharomyces Cerevisiae to Overproduce Squalene

Enhancement of squalene synthesis in Candida tropicalis via combinatorial metabolic engineering strategies to rebuild pathways

Genetic regulation and fermentation strategy for squalene production in Schizochytrium sp.

Dual cytoplasmic‐peroxisomal engineering for high‐yield production of sesquiterpene α‐humulene in Yarrowia lipolytica

Enhanced squalene production by modulation of pathways consuming squalene and its precursor

Combining Metabolic Engineering and Lipid Droplet Storage Engineering for Improved α-Bisabolene Production in Yarrowia Lipolytica.

Recent advances in the microbial production of squalene

Metabolic Engineering of Yarrowia Lipolytica for Heterologous Oleanolic Acid Production